138 related articles for article (PubMed ID: 31306564)
1. Budesonide use and misuse in sports: Elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations.
Coll S; Monfort N; Matabosch X; Papakonstantinou K; Pérez-Mañá C; Mateus JA; Ventura R
Drug Test Anal; 2020 May; 12(5):629-636. PubMed ID: 31306564
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports.
Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
Ther Drug Monit; 2013 Feb; 35(1):118-28. PubMed ID: 23318282
[TBL] [Abstract][Full Text] [Related]
3. Elimination profiles of betamethasone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Feb; 13(2):348-359. PubMed ID: 32949107
[TBL] [Abstract][Full Text] [Related]
4. Additional studies on triamcinolone acetonide use and misuse in sports: Elimination profile after intranasal and high-dose intramuscular administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Steroids; 2019 Nov; 151():108464. PubMed ID: 31344406
[TBL] [Abstract][Full Text] [Related]
5. Identification of budesonide metabolites in human urine after oral administration.
Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
Anal Bioanal Chem; 2012 Aug; 404(2):325-40. PubMed ID: 22573060
[TBL] [Abstract][Full Text] [Related]
6. Elimination profiles of prednisone and prednisolone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pozo OJ; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Mar; 13(3):571-582. PubMed ID: 33161623
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.
Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Marcos J; Segura J; Ventura R
J Steroid Biochem Mol Biol; 2015 Jan; 145():94-102. PubMed ID: 25260353
[TBL] [Abstract][Full Text] [Related]
8. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
[TBL] [Abstract][Full Text] [Related]
9. Elimination profile of triamcinolone in urine following oral administration.
Chen TT; Tseng YC; Huang TY; Chang-Chien GP; Hsu MC
Drug Test Anal; 2018 May; 10(5):860-864. PubMed ID: 29155490
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the urinary excretion of prednisolone and metabolites after nasal administration: Relevance to doping control.
Deventer K; Polet M; Van Gansbeke W; Hooghe F; Van Hoecke H; Van Eenoo P
Drug Test Anal; 2021 Nov; 13(11-12):1897-1905. PubMed ID: 34081842
[TBL] [Abstract][Full Text] [Related]
11. BUDESONIDE TREATMENT OF PROFESSIONAL ATHLETES AND ANTI-DOPING TESTING--CASE STUDIES.
Kaliszewski P; Kończak D; Chołbiński P; Wicka M; Michalak D; Kwiatkowska D; Lewandowska-Pachecka S; Namieśnik J; Pokrywka A
Acta Pol Pharm; 2016; 73(1):229-37. PubMed ID: 27008817
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucocorticoid administration on the steroid profile.
Coll S; Matabosch X; Garrostas L; Perez-Maña C; Ventura R
Drug Test Anal; 2018 Jun; 10(6):947-955. PubMed ID: 29278450
[TBL] [Abstract][Full Text] [Related]
13. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
14. Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra-articular administration.
Coll S; Matabosch X; Llorente-Onaindia J; Carbó ML; Pérez-Mañá C; Monfort N; Monfort J; Ventura R
Drug Test Anal; 2019 Nov; 11(11-12):1589-1600. PubMed ID: 31087549
[TBL] [Abstract][Full Text] [Related]
15. Is zebrafish (Danio rerio) water tank model applicable for the assessment of glucocorticoids metabolism? The budesonide assessment.
de Araujo ALD; Nunes IKDC; Sardela VF; Pereira HMG; Cabral LM; Anselmo CS
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122826. PubMed ID: 34225244
[TBL] [Abstract][Full Text] [Related]
16. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
[TBL] [Abstract][Full Text] [Related]
18. Effect of hyperhydration on the pharmacokinetics and detection of orally administered budesonide in doping control analysis.
Athanasiadou I; Vonaparti A; Dokoumetzidis A; Saleh A; Mbeloug M; Al-Maadheed M; Valsami G; Georgakopoulos C
Scand J Med Sci Sports; 2019 Oct; 29(10):1489-1500. PubMed ID: 31206799
[TBL] [Abstract][Full Text] [Related]
19. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.
Deventer K; Pozo OJ; Delbeke FT; Van Eenoo P
Drug Test Anal; 2012 Jun; 4(6):449-54. PubMed ID: 22447497
[TBL] [Abstract][Full Text] [Related]
20. Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control.
Brooker L; Cawley A; Kazlauskas R; Goebel C; George A
Drug Test Anal; 2012 Dec; 4(12):951-61. PubMed ID: 22987608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
